article · Toxicology and Applied Pharmacology

Empagliflozin and pirfenidone confer renoprotection through suppression of glycogen synthase kinase-3β and promotion of tubular regeneration in rats with induced metabolic syndrome

20242 citationsZagazig University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Pancreatic function and diabetes
Tuberous Sclerosis Complex Research
Renal and related cancers

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.taap.2024.116892

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.